These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12908728)

  • 21. Therapeutic potential of interleukin-6 in preventing obesity- and alcohol-associated fatty liver transplant failure.
    Gao B
    Alcohol; 2004 Aug; 34(1):59-65. PubMed ID: 15670667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations of hepatic ATP homeostasis and respiratory chain during development of non-alcoholic steatohepatitis in a rodent model.
    Serviddio G; Bellanti F; Tamborra R; Rollo T; Romano AD; Giudetti AM; Capitanio N; Petrella A; Vendemiale G; Altomare E
    Eur J Clin Invest; 2008 Apr; 38(4):245-52. PubMed ID: 18339004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of iron overload in a rat nutritional model of non-alcoholic fatty liver disease.
    Kirsch R; Sijtsema HP; Tlali M; Marais AD; Hall Pde L
    Liver Int; 2006 Dec; 26(10):1258-67. PubMed ID: 17105592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol.
    Yasutake K; Nakamuta M; Shima Y; Ohyama A; Masuda K; Haruta N; Fujino T; Aoyagi Y; Fukuizumi K; Yoshimoto T; Takemoto R; Miyahara T; Harada N; Hayata F; Nakashima M; Enjoji M
    Scand J Gastroenterol; 2009; 44(4):471-7. PubMed ID: 19058085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel aminosterol reverses diabetes and fatty liver disease in obese mice.
    Takahashi N; Qi Y; Patel HR; Ahima RS
    J Hepatol; 2004 Sep; 41(3):391-8. PubMed ID: 15336441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model.
    Veteläinen R; van Vliet A; van Gulik TM
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1526-33. PubMed ID: 17716355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
    Zheng S; Hoos L; Cook J; Tetzloff G; Davis H; van Heek M; Hwa JJ
    Eur J Pharmacol; 2008 Apr; 584(1):118-24. PubMed ID: 18329014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease.
    Yamamoto M; Iwasa M; Iwata K; Kaito M; Sugimoto R; Urawa N; Mifuji R; Konishi M; Kobayashi Y; Adachi Y
    J Gastroenterol Hepatol; 2007 Apr; 22(4):498-503. PubMed ID: 17376040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impairment of mitochondrial oxidative phosphorylation in rat fatty liver exposed to preservation-reperfusion injury.
    Caraceni P; Bianchi C; Domenicali M; Maria Pertosa A; Maiolini E; Parenti Castelli G; Nardo B; Trevisani F; Lenaz G; Bernardi M
    J Hepatol; 2004 Jul; 41(1):82-8. PubMed ID: 15246212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice.
    Sohet FM; Neyrinck AM; Pachikian BD; de Backer FC; Bindels LB; Niklowitz P; Menke T; Cani PD; Delzenne NM
    Biochem Pharmacol; 2009 Dec; 78(11):1391-400. PubMed ID: 19632207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury.
    He S; Atkinson C; Evans Z; Ellett JD; Southwood M; Elvington A; Chavin KD; Tomlinson S
    J Immunol; 2009 Oct; 183(7):4764-72. PubMed ID: 19752222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model.
    Yalniz M; Bahcecioglu IH; Kuzu N; Poyrazoglu OK; Bulmus O; Celebi S; Ustundag B; Ozercan IH; Sahin K
    J Gastroenterol Hepatol; 2007 Nov; 22(11):2009-14. PubMed ID: 17914984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
    J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate.
    Forcheron F; Abdallah P; Basset A; del Carmine P; Haffar G; Beylot M
    Obesity (Silver Spring); 2009 Jul; 17(7):1381-9. PubMed ID: 19553925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-alcoholic steatohepatitis and metabolic syndrome.
    Machado M; Cortez-Pinto H
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):637-42. PubMed ID: 16912563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary single cell protein reduces fatty liver in obese Zucker rats.
    Gudbrandsen OA; Wergedahl H; Liaset B; Espe M; Mørk S; Berge RK
    Br J Nutr; 2008 Oct; 100(4):776-85. PubMed ID: 18346305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preservation of steatotic livers in IGL-1 solution.
    Ben Mosbah I; Roselló-Catafau J; Franco-Gou R; Abdennebi HB; Saidane D; Ramella-Virieux S; Boillot O; Peralta C
    Liver Transpl; 2006 Aug; 12(8):1215-23. PubMed ID: 16724331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease.
    Videla LA; Rodrigo R; Araya J; Poniachik J
    Free Radic Biol Med; 2004 Nov; 37(9):1499-507. PubMed ID: 15454290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatty acid composition and development of hepatic lipidosis during food deprivation--mustelids as a potential animal model for liver steatosis.
    Nieminen P; Mustonen AM; Kärjä V; Asikainen J; Rouvinen-Watt K
    Exp Biol Med (Maywood); 2009 Mar; 234(3):278-86. PubMed ID: 19144866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.